The New England Journal of Medicine (NEJM) Images in Clinical Medicine article type captures and illuminates the sense of visual discovery and variety that physicians experience every day in ...

The New England Journal of Medicine’s editor in chief, Eric Rubin, received a letter from the interim US attorney for the District of Columbia, Edward R. Martin Jr. in recent days in which the ...

The New England Journal of Medicine’s editor in chief, Eric Rubin, received a letter from the interim U.S. attorney for the District of Columbia, Edward R. Martin Jr. in recent days in which the ...

The New England Journal of Medicine received a letter suggesting that it was biased and compromised by external pressure. Other journals have also received the letter. By Teddy Rosenbluth A ...

New England Journal of Medicine Publishes Landmark Phase III Results for Genentech’s Itovebi, Showing More Than Doubling of Progression-Free Survival in Certain Type of HR-Positive Advanced ...

The next morning, The New England Journal of Medicine published its first-ever article acknowledging the devastation in Gaza. Over the preceding 17 months of what UN investigations and others have ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the New England Journal of Medicine (NEJM) has published a detailed ...

Visual Cognitive Skill. Published January 11, 1962. N Engl J Med 1962; 266: 103-104. ... New England Journal of Medicine. Volume 266 • Number 2 • January 11, 1962. Pages: 103-104. History.

This Double Take video from the New England Journal of Medicine describes a man with recurrent severe diffuse abdominal pain without obvious associated symptoms. Based on a Clinical Problem ...

This Double Take video from the New England Journal of Medicine describes the case of a man with persistent diffuse abdominal pain, fatigue, and anorexia with subsequent weight loss. Based on a ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) patients with a new all-tablet treatment showing impressive results.

New England Journal of Medicine Publishes Phase III Data Showing Single-dose Xofluza Significantly Reduces Influenza Virus Transmission Provided by Business Wire Apr 25, 2025, 5:00:00 AM.